Edesa Biotech, Inc. (EDSA) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts EDSA Hot Sheet
Join SI Premium – FREE
Edesa Biotech, Inc. (NASDAQ: EDSA) reported Q2 EPS of ($0.10), $0.07 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Edesa Biotech, Inc. (EDSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
